|Day Low/High||3.77 / 4.32|
|52 Wk Low/High||2.15 / 6.41|
Investors in Vivus, Inc. saw new options begin trading today, for the January 24th expiration.
New Program, Available Now, Integrates Qsymia to Help Bridge the Gap Between Lifestyle Interventions and Surgical Treatments
Investors in Vivus, Inc. saw new options become available today, for the January 10th expiration.
The list of biotech and drug stocks with billion-dollar market values almost doubled in 2013 -- a sign that investors loved speculation and were rewarded for it.
Investors in Vivus, Inc. saw new options begin trading today, for the December 27th expiration.
Trade-Ideas LLC identified Vivus (VVUS) as a "perilous reversal" (up big yesterday but down big today) candidate
These under-$10 stocks look poised to trade higher from current levels.
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
Orexigen Therapeutics is the best-performing obesity drug stock of 2013, topping rivals Vivus and Arena Pharma.
Contrave will be resubmitted for FDA approval "within a few weeks," Orexigen said.
New Guidelines and Publication Encourage Physicians and Patients to Work Together to Find the Right Treatment Plan, Which May Include Medication
Kyle Bass’ Hayman Capital got in on a few embattled and controversial stocks during the September quarter. His latest 13F filing shows that his new stocks for the September quarter included Herb...
Investors in Vivus, Inc. saw new options become available today, for the November 22nd expiration.
Insiders at these companies have been scooping up shares of their own stock lately.
Stocks with insider trader activity include MOS, VVUS, XRAY, PSX and IVZ
The top 10 open-market insider purchases and sales filed at the SEC Tuesday.
Chris Lau, Kapitall: ArenaA and a partner will expand marketing efforts for a weight loss drug, but is there more room [...]
Cramer says to be careful with Vivus but he sees CVS going higher.
Investors in Vivus, Inc. saw new options become available today, for the November 8th expiration.
Once-Daily Extended-Release Qsymia Achieved 10% Weight Loss, Was Well Tolerated and Improved Blood Pressure
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.